Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Cure rate model with interval censored data.

Yang-Jin Kim1, Myoungshic Jhun

  • 1Institute of Statistics, Korea University, Seoul 136-701, Korea.

Statistics in Medicine
|May 23, 2007
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Dynamic prediction of interval-censored failure time data with longitudinal marker.

Statistical methods in medical research·2026
Same author

Quantile regression model for interval-censored data with competing risks.

Journal of applied statistics·2025
Same author

Tracing Metastatic Evolutionary Patterns in Lung Adenocarcinoma: Prognostic Dissection Based on a Multi-state Model.

Cancer research and treatment·2025
Same author

Joint model for bivariate zero-inflated recurrent event data with terminal events.

Journal of applied statistics·2022
Same author

Joint model for recurrent event data with a cured fraction and a terminal event.

Biometrical journal. Biometrische Zeitschrift·2019
Same author

Non-crossing weighted kernel quantile regression with right censored data.

Lifetime data analysis·2014
Same journal

Interpretable Bayesian Modeling for Multireader Multicase Studies: Addressing Overdispersion and Limited Sample Size in Diagnostic Enhancement Evaluation.

Statistics in medicine·2026
Same journal

Adaptive Sequential Multiple Hypotheses Testing for Concomitant Vaccine Safety Surveillance.

Statistics in medicine·2026
Same journal

Novel Distance Regression for Repeated Outcomes With Missing Data: Applications to Longitudinal and Crossover Studies of Microbiome Beta-Diversity.

Statistics in medicine·2026
Same journal

Optimal Weighted Tests for Replication Studies and the 'Two-Trials Rule' With Multiple Hypotheses.

Statistics in medicine·2026
Same journal

Identifiable Copula-Double-Cox Models: A Fully Parametric Framework for Dependent Right-Censored Survival Data.

Statistics in medicine·2026
Same journal

Moving From Individualized Risk-Based Prevention to Benefit-Based Prevention: Estimating Individualized Life-Years Gained From Prevention Services as a Basis for Eligibility.

Statistics in medicine·2026
See all related articles

This study introduces a cure rate model for interval censored data, enhancing cancer trial analysis. The model effectively estimates cure fractions and survival times, improving treatment evaluation for diseases like cancer.

Area of Science:

  • Biostatistics
  • Survival Analysis
  • Clinical Trials

Background:

  • Cancer treatments aim to cure patients or prolong survival for non-cured individuals.
  • Cure rate models combine cure fraction and survival models for comprehensive analysis.
  • Interval censored data, common in disease progression studies, present unique analytical challenges.

Purpose of the Study:

  • To develop and apply a cure rate model for interval censored data.
  • To incorporate frailty models to characterize associations between cure fraction and survival.
  • To utilize an approximate likelihood approach and EM algorithm for parameter estimation.

Main Methods:

  • Utilized an approximate likelihood approach for interval censored data.
  • Introduced a frailty model with a common normal frailty effect to link cure fraction and survival.

Related Experiment Videos

  • Employed the EM algorithm for parameter estimation and multiple imputation for variance estimation.

    • Main Results:

    • The proposed cure rate model effectively analyzes interval censored data.
    • Demonstrated the utility of frailty models in capturing cure-survival associations.
    • Applied the methodology to a smoking cessation study, identifying effective covariates for relapse and duration.

    Conclusions:

    • The developed cure rate model provides a robust framework for analyzing interval censored data in clinical studies.
    • The integration of frailty models enhances the understanding of cure fraction and survival time relationships.
    • The approach is applicable to various diseases, including cancer and smoking cessation, aiding in treatment efficacy assessment.